Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 1096 AL 1110

Cardiovascular pharmacology of dopaminergic agents in humans: a review

Palma JA, Gomez Casanovas JG.

Clin Auton Res. 2026 Aug;36(4):427-443. doi: 10.1007/s10286-026-01229-w. Epub 2026 Jul 3.

Of mice and men-The emerging oral-gut-brain axis of health and disease

Hernandez-Kapila YL, Weisenberger DJ.

Periodontol 2000. 2026 Jul 2. doi: 10.1111/prd.70064. Online ahead of print.

Genetic Code Expansion, Enzymatic Modification, and C-Terminal Labeling Enable Facile Production of Highly Modified α-Synuclein

Abakah B, Shimogawa M, Miranda-Castrodad P, Rhoades E, Petersson EJ.

bioRxiv [Preprint]. 2026 Jun 25:2026.06.24.734353. doi: 10.64898/2026.06.24.734353.

Microglia-Specific Molecular Magnetic Resonance Imaging Probe Enables Noninvasive Separation of Parkinsonian Mice from Controls

Sun X, Badachhape A, Reid TE, Ngan E, Monga S, Chin J, Annapragada A, Lowe H, Toyang N, Tanifum E.

bioRxiv [Preprint]. 2026 Jun 26:2026.06.23.734093. doi: 10.64898/2026.06.23.734093.

Cholinergic interneuron control of GABAergic circuits targeting spiny projection neurons is disrupted in parkinsonian models

Belal M, Perez-Rosello T, Guven EB, Kocaturk S, Xie Z, Ilijic E, Tkatch T, Li J, Dauer W, Assous M, Tepper JM, Clarke VRJ, Surmeier DJ.

bioRxiv [Preprint]. 2026 Jun 22:2026.06.17.732978. doi: 10.64898/2026.06.17.732978.

Neuropsychological outcomes comparing deep brain stimulation and best medical treatment for Parkinson's disease: a systematic review and meta-analysis

Ning J, Lv X, You J, Zhou X, An C, Zhou Z.

Front Psychol. 2026 Jun 18;17:1865587. doi: 10.3389/fpsyg.2026.1865587. eCollection 2026.

Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort

Lange LM, Cerquera-Cleves C, Tan AH, Lim SY, Okubadejo NU, Lin CH, Chen PS, Shin JH, Ahmad-Annuar A, Screven LA, Chelban V, Dilliot AA, Fienemann A, Galvelis KG, Houlden H, Iwaki H, Jaunmuktane Z, Cullinane PW, Warner T, Junker J, Kanana Y, Sarmiento IJK, Klein C, Kung PJ, Leonard HL, Mencacci NE, Nalls MA, Real R, Sassi SB, Trinh J, Vitale D, Westenberger A, Wu LY, Singleton AB, Morris HR, Lohmann K, Blauwendraat C, Heutink P, Fang ZH; Global Parkinson’s Genetics Program (GP2).

medRxiv [Preprint]. 2026 Jun 22:2026.06.12.26354932. doi: 10.64898/2026.06.12.26354932.

Sex-biased Genetic Risk Loci and Causal Brain Proteins in Parkinson's Disease

Cook N, Zeng Y, Fu T, Yang C, Sivasankaran SK, Nguyen P; FinnGen; Wingo AP, Wingo TS, Foo JN, Davis AA, Ibanez L, Cruchaga C, Belloy ME.

medRxiv [Preprint]. 2026 Jun 25:2026.06.23.26356345. doi: 10.64898/2026.06.23.26356345.

Large-scale functional annotation establishes a reference framework for human LRRK2 variants

Cheung A, Pratuseviciute N, Black K, Lis P, Phung T, Cavin M, Morel G, Saari A, Huin V, Zittel-Dirks S, Tonelli F, Riebenbauer B, Gasser T, Ruiz-Martinez J; Global Parkinson’s Genetics Program (GP2); Morris HR, Lange LM, Dilliott A, Goldstein O, Shani S, Arnaud L, Zimprich A, Pirker W, Klein C, Alcalay R, Lohmann K, Alessi DR, Sammler E.

medRxiv [Preprint]. 2026 Jun 26:2026.06.17.26355034. doi: 10.64898/2026.06.17.26355034.

Parkinson's disease: Individual placebo responses are predicted by baseline expression of a striato-limbic network

Barbero J, Vo A, Strohl JJ, Vacca S, Tang CC, Nguyen N, Unadkat P, Ma Y, Peng S, Niethammer M, Brakedal B, Wallin J, Markaki I, Svenningsson P, Kaplitt MG, Tzoulis C, Eidelberg D.

Res Sq [Preprint]. 2026 Jun 24:rs.3.rs-10119103. doi: 10.21203/rs.3.rs-10119103/v1.

Riemannian geometry meets fMRI: the advantages of modeling correlation manifolds and eigenvector subspaces

Severino M, Moretto M, McCutcheon RA, Veronese M.

Res Sq [Preprint]. 2026 Jun 25:rs.3.rs-8524201. doi: 10.21203/rs.3.rs-8524201/v1.

The central role of endoplasmic reticulum stress in Parkinson's disease and targeted therapeutic strategies

Chen X, Zhao Z, Yao X, Wei Y, Li X, Chen B, Sun H.

Biochem Pharmacol. 2026 Oct;252:118218. doi: 10.1016/j.bcp.2026.118218. Epub 2026 Jul 3.

The road towards faster development of novel pharmacotherapies for persons with Parkinson's disease

Outeiro TF, Bloem BR, Kalia LV, Ferreira JJ.

J Parkinsons Dis. 2026 Jul;16(2_suppl):3-5. doi: 10.1177/1877718X261463419. Epub 2026 Jul 3.

The landscape of artificial intelligence in neurodegenerative diseases: a systematic review

Endrizzi W, Ragni F, Bovo S, Chandra A, Moroni M, Jurman G, Osmani V.

Commun Med (Lond). 2026 Jul 3. doi: 10.1038/s43856-026-01669-5. Online ahead of print.

Limb apraxia in Parkinson's disease and atypical parkinsonian syndromes: a systematic review

Smaragdaki E, Stamelos I, Tsolaki M, Scarmeas N, Potagas C, Stefanis L, Papageorgiou SG, Constantinides VC.

Neurol Sci. 2026 Jul 4;47(8):610. doi: 10.1007/s10072-026-09215-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias